Trial Profile
A Phase I, Open-Label, One-Way, Crossover, Drug-Drug Interaction Study Assessing the Effect of Mefenamic Acid on the Pharmacokinetics (PK) of Epacadostat in Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 27 Sep 2018
Price :
$35
*
At a glance
- Drugs Epacadostat (Primary) ; Mefenamic acid
- Indications Colorectal cancer; Fallopian tube cancer; Gastric cancer; Gastrointestinal stromal tumours; Glioblastoma; Head and neck cancer; Malignant melanoma; Non-small cell lung cancer; Oesophageal cancer; Ovarian cancer; Pancreatic cancer; Peritoneal cancer; Prostate cancer; Renal cell carcinoma; Sarcoma; Solid tumours; Urogenital cancer
- Focus Pharmacokinetics
- 27 Sep 2018 New trial record
- 01 Sep 2018 Results published in the Clinical Pharmacology in Drug Development Journal: 2018 Annual Meeting of the American College of Clinical Pharmacology.